Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects
about
Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureContribution of human immunodeficiency virus type 1 minority variants to reduced drug susceptibility in patients on an integrase strand transfer inhibitor-based therapyHIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, ChinaSensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism.Ultra-deep mutant spectrum profiling: improving sequencing accuracy using overlapping read pairsSilent mutations at codons 65 and 66 in reverse transcriptase alleviate indel formation and restore fitness in subtype B HIV-1 containing D67N and K70R drug resistance mutations.Applications of next-generation sequencing technologies to diagnostic virology.Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing.Clinical implications of HIV-1 minority variantsLow-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure.The population genetics of drug resistance evolution in natural populations of viral, bacterial and eukaryotic pathogensThe expanding scope of DNA sequencing.Recent advances in research of HIV infection: implications of viral and host genetics on treatment and prevention.Deep sequencing: becoming a critical tool in clinical virology.Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine.Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE.VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering.Improved prediction of salvage antiretroviral therapy outcomes using ultrasensitive HIV-1 drug resistance testing.Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: results from the REALIZE trial.Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries.
P2860
Q28539186-FABE83AF-9DD7-4569-A0DC-0E961C036331Q28541754-FA7A7FDB-01E7-4FD5-BA02-35CAE04FED0EQ28550283-C3194916-E156-47B4-896E-E149CE05D6C5Q33622927-D693A98E-E1A7-4380-A5AD-CBF00A5F93B1Q34583054-B5637855-16FB-4692-8D41-3D65C402DC4BQ35237036-AD627D05-C929-46B7-B682-F8E326B41174Q35600172-9116F6C2-D2F5-491F-9F9A-0571A51885F1Q36507279-0D8F04BD-6FD8-4298-BBB8-1FBBCC3AA05FQ36811249-C0A3C3D2-C8B6-4E6A-915A-C4F5425CD590Q36933330-ABBF7CBB-2D83-4745-8739-43F3AA326DBFQ37090265-63476A87-63C2-46B7-8C87-A611C3B0477FQ38058682-B3909446-5412-425C-A23D-0CFCC3A05989Q38095239-5D135AE7-1A12-4A60-A4E1-3A5DF4162D67Q38226696-0DFA9CD1-171C-412C-B7DC-11EB433C4999Q38389563-106A12BB-F159-4511-A113-FAAE9244F685Q38738833-D76D3ADF-A47F-4861-A916-A968154339ABQ40978625-B8F78419-0858-4D9D-9A1B-111B8B2C91DAQ41758916-956390E0-23BE-426C-AB88-D3CF52FC666DQ42215713-45164359-7B0A-4F84-B0FC-C491DB15B8BDQ42234370-638E470F-5893-4CCC-A4B3-EC1B8EDFBA72Q42982310-BCB41055-A64F-4818-9D49-D1E84099AAA4Q46499496-F4EA172E-A7FF-43C6-A032-7B8DDED7B976
P2860
Added value of deep sequencing relative to population sequencing in heavily pre-treated HIV-1-infected subjects
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Added value of deep sequencing ...... reated HIV-1-infected subjects
@ast
Added value of deep sequencing ...... reated HIV-1-infected subjects
@en
Added value of deep sequencing ...... reated HIV-1-infected subjects
@nl
type
label
Added value of deep sequencing ...... reated HIV-1-infected subjects
@ast
Added value of deep sequencing ...... reated HIV-1-infected subjects
@en
Added value of deep sequencing ...... reated HIV-1-infected subjects
@nl
prefLabel
Added value of deep sequencing ...... reated HIV-1-infected subjects
@ast
Added value of deep sequencing ...... reated HIV-1-infected subjects
@en
Added value of deep sequencing ...... reated HIV-1-infected subjects
@nl
P2093
P2860
P1433
P1476
Added value of deep sequencing ...... reated HIV-1-infected subjects
@en
P2093
Alexander Thielen
Christian Pou
David Dalmau
Federico García
Francisco M Codoñer
Lidia Ruiz
Miguel Álvarez-Tejado
Rafael Delgado
Roger Paredes
P2860
P304
P356
10.1371/JOURNAL.PONE.0019461
P407
P577
2011-01-01T00:00:00Z